Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NEXGEL, Inc. - SIC # 2840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
NXGL
Nasdaq
2840
nexgel.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NEXGEL, Inc.
NEXGEL Announces Date for Investor Update Call
- Sep 16th, 2026 7:29 am
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
- Aug 20th, 2026 2:05 pm
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp
- Aug 17th, 2026 8:54 am
NEXGEL Reports Second Quarter 2026 Financial Results
- Aug 17th, 2026 6:00 am
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
- Jun 4th, 2026 7:00 am
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
- May 19th, 2026 7:00 am
Nexgel (NXGL) Q1 2026 Earnings Transcript
- May 15th, 2026 10:54 am
NEXGEL, Inc. Q1 2026 Earnings Call Summary
- May 14th, 2026 6:30 am
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
- May 13th, 2026 6:30 am
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
- May 12th, 2026 8:27 am
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
- May 6th, 2026 7:00 am
NEXGEL Appoints Ian Blackman as Chief Financial Officer
- Apr 27th, 2026 7:00 am
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
- Apr 21st, 2026 7:00 am
Celularity Announces Closing of Transaction with NexGel
- Apr 21st, 2026 6:30 am
NEXGEL, Inc. Q4 2025 Earnings Call Summary
- Apr 21st, 2026 6:30 am
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
- Apr 17th, 2026 1:37 pm
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
- Apr 15th, 2026 2:12 pm
NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...
- Apr 8th, 2026 7:00 pm
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
- Apr 8th, 2026 2:05 pm
Scroll